TFG Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

TFG Asset Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,903,662	Closed	-$27.2M	–	33
2023 Q4	$27.2M	Hold	1,903,662	–	–	6.54%	4
2023 Q3	$29.4M	Hold	1,903,662	–	–	5.37%	5
2023 Q2	$29.9M	Hold	1,903,662	–	–	4.04%	7
2023 Q1	$31.4M	Hold	1,903,662	–	–	4.2%	8
2022 Q4	$29.7M	Buy	1,903,662 +220,828	+13%	+$3.08M	4.25%	8
2022 Q3	$21.8M	Buy	1,682,834 +407,178	+32%	+$5.66M	2.63%	13
2022 Q2	$17.9M	Hold	1,275,656	–	–	1.23%	25
2022 Q1	$18.3M	Hold	1,275,656	–	–	0.83%	31
2021 Q4	$17.4M	Sell	1,275,656 -71,277	-5%	-$1,000K	1.05%	25
2021 Q3	$22.1M	Hold	1,346,933	–	–	1.35%	18
2021 Q2	$22.7M	Buy	1,346,933 +757,543	+129%	+$12.9M	1.24%	20
2021 Q1	$10.8M	Sell	589,390 -853,662	-59%	-$15.4M	0.77%	23
2020 Q4	$26.3M	Buy	1,443,052 +789,390	+121%	+$13.9M	1.76%	13
2020 Q3	$11.7M	Hold	653,662	–	–	1.07%	23
2020 Q2	$11.7M	Buy	653,662 +256,000	+64%	+$4.6M	1.56%	16
2020 Q1	$6.04M	Hold	397,662	–	–	1.04%	19
2019 Q4	$7.85M	Hold	397,662	–	–	1.17%	22
2019 Q3	$6.84M	Buy	397,662 +218,700	+122%	+$3.78M	1.22%	20
2019 Q2	$3.17M	Buy	178,962 +105,301	+143%	+$1.92M	0.46%	34
2019 Q1	$1.5M	Buy	+73,661	New	+$1.48M	0.19%	43

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TFG Asset Management's TAK Position: Q1 2024 in Review

TFG Asset Management sold out of Takeda Pharmaceutical (TAK) in Q1 2024, closing a stake of 1,903,662 shares — an estimated $27.2M sold.

TFG Asset Management first reported a position in TAK in Q1 2019 and held it in 20 quarters. The position peaked at $31.4M in Q1 2023. 314 funds tracked by Wall St. Rank hold TAK as of Q1 2024.

TFG Asset Management reported no remaining Takeda Pharmaceutical position as of Q1 2024 after selling out during the quarter.
TFG Asset Management sold 1,903,662 Takeda Pharmaceutical shares in Q1 2024, an estimated $27.2M.
TFG Asset Management first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 20 quarters.
TFG Asset Management's Takeda Pharmaceutical position peaked at $31.4M in Q1 2023.
314 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2024.

Based on TFG Asset Management's 13F filing for Q1 2024, filed 15 May 2024.